A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
NYS Entity Status
NYS Filing Date
APRIL 04, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - CEDAR 3 LLC
AROUND THE WEB
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
- New CRISPR technique could accelerate a cure for Huntington's disease and ALS
By Lulu Chang - Monday Aug 14, 2017
A modified version of the CRISPR/Cas9 tool could be used to track RNA in live cells using a method known as RNA-targeting Cas9. This, in turn, could be used to cure ALS and Huntington's disease.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
- SF Deltas overcome early goal to beat NY Cosmos 2-1
By Douglas Zimmerman - Sunday Aug 6, 2017
The second largest crowd in San Francisco Deltas early history saw the home team overcome an early goal to pull out a 2-1 victory over the defending champions New York Cosmos. 3,369 fans were treated to a 36th minute tying goal by Deltas defender Patrick Hopkins and a penalty kick by Tommy Heinemann to complete